Dr. Andrew S. Kennedy
Claim this profileHenrico Doctor's Hospital
Area of expertise
Breast Cancer
Andrew S. Kennedy has run 2 trials for Breast Cancer. Some of their research focus areas include:
Prostate Adenocarcinoma
Andrew S. Kennedy has run 1 trial for Prostate Adenocarcinoma.
Affiliated Hospitals
Henrico Doctors Hospital
Mission Hospital
Clinical Trials Andrew S. Kennedy is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting
2 awards
Phase 3
4 criteria
Herceptin Hylecta or Phesgo + Chemotherapy
for Uterine Cancer
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, trastuzumab and hyaluronidase-zzxf (Phesgo \[TM\]) to the usual chemotherapy (paclitaxel and carboplatin) works to shrink tumors in patients with HER2 positive endometrial cancer. Trastuzumab and pertuzumab are monoclonal antibodies and forms of targeted therapy that attach to specific molecules (receptors) on the surface of tumor cells, known as HER2 receptors. When trastuzumab or pertuzumab attach to HER2 receptors, the signals that tell the cells to grow are blocked and the tumor cell may be marked for destruction by the body's immune system. Hyaluronidase is an endoglycosidase. It helps to keep pertuzumab and trastuzumab in the body longer, so that these medications will have a greater effect. Hyaluronidase also allows trastuzumab and trastuzumab/pertuzumab to be given by injection under the skin and shortens their administration time compared to trastuzumab or pertuzumab alone. Paclitaxel is a taxane and in a class of medications called antimicrotubule agents. It stops tumor cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of tumor cells. Giving Herceptin Hylecta or Phesgo in combination with paclitaxel and carboplatin may shrink the tumor and prevent the cancer from coming back in patients with HER2 positive endometrial cancer.
Recruiting
2 awards
Phase 3
More about Andrew S. Kennedy
Clinical Trial Related
3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Andrew S. Kennedy has experience with
- Radiation
- Tamoxifen
- Anastrozol
- Letrozole
- Exemestane
- Relugolix
Breakdown of trials Andrew S. Kennedy has run
Breast Cancer
Prostate Adenocarcinoma
Brain Metastasis
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew S. Kennedy specialize in?
Andrew S. Kennedy focuses on Breast Cancer and Prostate Adenocarcinoma. In particular, much of their work with Breast Cancer has involved ER positive patients, or patients who are HER2 negative.
Is Andrew S. Kennedy currently recruiting for clinical trials?
Yes, Andrew S. Kennedy is currently recruiting for 6 clinical trials in Richmond Virginia. If you're interested in participating, you should apply.
Are there any treatments that Andrew S. Kennedy has studied deeply?
Yes, Andrew S. Kennedy has studied treatments such as Radiation, Tamoxifen, Anastrozol.
What is the best way to schedule an appointment with Andrew S. Kennedy?
Apply for one of the trials that Andrew S. Kennedy is conducting.
What is the office address of Andrew S. Kennedy?
The office of Andrew S. Kennedy is located at: Henrico Doctor's Hospital, Richmond, Virginia 23229 United States. This is the address for their practice at the Henrico Doctor's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.